Can I get it?
Yes, if a doctor decides it is right for you. Rybelsus is authorised in the EU and can be prescribed after a medical review.
Rybelsus · Antwerp
Rybelsus in Antwerp: what you should know.
APPROVED IN THE EURybelsus is authorised in the EU.
Rybelsus is no longer offered by Hi Doctor. Our doctors can review your case in Antwerp and consider other weight management treatments with EU authorisation. A prescription is only issued if it is suitable for you.
Full refund if a review is not approved
IN PLAIN TERMS
What Rybelsus is, and what to know
Rybelsus is a tablet form of semaglutide. It is licensed in the European Union, but only for one thing: controlling blood sugar in adults with type 2 diabetes. It is not licensed in the EU as a weight-loss medicine. People taking it for diabetes often lose some weight as a side effect, and that is where its reputation as a weight-loss pill comes from, but prescribing Rybelsus purely to lose weight is off-label, meaning it is being used outside what regulators have assessed and approved. A separate, higher-dose oral semaglutide tablet was authorised in the EU for weight management in July 2026, so if you are looking for a semaglutide tablet for weight, that is a different product and a doctor should decide what is appropriate for you.
Rybelsus has been authorised for use in the EU since 3 April 2020, so an EU-licensed doctor can prescribe it when it is clinically appropriate for you.
Learn more about peptides at Peptidepedia.
What can I take instead?
Our doctors review every Weight loss option and recommend what fits your history and goals.
See all Weight loss optionsWhat do the studies show?
Every trial behind Rybelsus is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.
Jump to the studiesLocal consultation facts
Can I get Rybelsus in Antwerp?
Not through Hi Doctor. Hi Doctor does not prescribe Rybelsus. People in Antwerp, Belgium, can request an online consultation for Weight loss with an EU-licensed doctor, who may recommend an available option when clinically appropriate. If approved, the EU prescription arrives as a PDF for a pharmacist in Belgium, who dispenses the locally marketed equivalent containing Oral-semaglutide.
Availability
Hi Doctor does not prescribe Rybelsus. The links below show options in Weight loss that our doctors can assess.
- Country
- Belgium
- Language of service
- Spanish and English
- Prescription turnaround
- Doctor reply in under 2 hours on average; a prescription only if the doctor approves
- Honoured locally
- PDF honoured locally for an equivalent containing Oral-semaglutide
How the EU prescription works where you are: In Belgium, show the approved prescription PDF to a pharmacist. Each pharmacy decides whether it can dispense it; if it does, the pharmacist dispenses the locally marketed equivalent containing Oral-semaglutide.
TREATMENT OPTIONS
Available medical weight-management options
An EU-licensed doctor decides case by case. We never prescribe without evaluation.
Rx · GLP-1
Prescription only
Semaglutide (Wegovy / Ozempic)
Weekly GLP-1 receptor agonist. A doctor may prescribe it if your BMI and history match the indications. Requires follow-up.
Weekly injection pen
Rx · GLP-1 / GIP
Prescription only
Tirzepatide (Mounjaro)
Dual GLP-1/GIP agonist. Assessed by the doctor based on comorbidities and the patient's BMI.
Weekly injection pen
Rx · GLP-1
Prescription only
Liraglutide (Saxenda)
Daily GLP-1 agonist. Indicated in selected patients with elevated BMI after medical evaluation.
Daily injection pen
Rx · lipase inhibitor
Prescription only
Orlistat 120mg
Fat-absorption inhibitor. A non-GLP-1 alternative a doctor may consider based on your history.
Capsules
You pay for any medication separately at the pharmacy you choose. Hi Doctor does not sell medications.
VERIFIED EVIDENCE
Rybelsus: evidence and regulatory guide.
WHAT IT IS
How it works
A daily tablet containing semaglutide, a copy of the gut hormone GLP-1, which helps the body release insulin after meals and lowers blood sugar.
- GLP-1
DEVELOPMENT STAGE
EU-authorised medicine
Trial register1 registered trial
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| PIONEER 4NCT02863419 | Adults with type 2 diabetes not adequately controlled on metformin, with or without an SGLT-2 inhibitor | 711 | Read out | n/a |
What the studies reported
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
Peer-reviewed
Pratley RE, Amod A, Hoff ST, et al. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4). Lancet. 2019. doi:10.1016/S0140-6736(19)31271-1 (PMID 31186120)| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| Oral semaglutide 14 mg daily | −4.7 kg body weight | 26 |
| Oral semaglutide 14 mg daily | −5.0 kg body weight | 52 |
| Liraglutide 1.8 mg daily by injection (comparator arm) | −3.1 kg body weight | 52 |
| Placebo | −1.2 kg body weight | 52 |
PIONEER 4 was a type 2 diabetes trial whose main purpose was to measure blood-sugar control; weight change was a secondary measurement in people with diabetes, not a test of Rybelsus as a weight-loss treatment, and Rybelsus has no EU weight-management indication.
NAMED SAFETY SIGNALS
What has been reported with Rybelsus.
Nausea
Very common in the Rybelsus product information, reported in around 15% of people taking semaglutide; usually mild to moderate and settling over time.
Diarrhoea
Very common in the Rybelsus product information, reported in around 10% of people taking semaglutide.
Vomiting
Reported in around 7% of people taking semaglutide in the Rybelsus product information.
Off-label use for weight loss
Rybelsus is authorised in the EU only for type 2 diabetes. Prescribing it purely for weight loss falls outside its authorised indication, so the EU-assessed benefit-risk balance for that use has not been established.
FREQUENTLY ASKED QUESTIONS
Questions about Rybelsus.
OTHER WEIGHT LOSS TREATMENTS